TY - JOUR
T1 - The impact of motivational interviewing on self-perceived burden in patients receiving therapeutic plasma exchange
AU - Dill, Rebecca
AU - Olson, Dai Wai M.
AU - Session-Augustine, Nellie
AU - Mariani, Dara
AU - Stutzman, Sonja E.
N1 - Funding Information:
The authors would like to thank the entire Apheresis team for their support in this study. Additionally, we would like to thank the Neuroscience Nursing Research Center for their support of this project, especially Julia Kincaide for her work in completing MI sessions with patients.
Publisher Copyright:
© 2018 Wiley Periodicals, Inc.
PY - 2018/10
Y1 - 2018/10
N2 - Background: Autoimmune disorders and neurodegenerative disorders take a physical and emotional toll on patients that undergo therapeutic plasma exchange (TPE) treatments. Previous literature has shown that these patients may feel a greater sense of self-burden. Motivational Interviewing (MI) is a technique used in various settings that has the potential to decrease feelings of self-burden. MI for patients who receive TPE has not been tested. The purpose of this study was to examine the impact of MI in patients with a neurodegenerative diagnosis (eg, transverse myelitis, myasthenia gravis, multiple sclerosis, and chronic inflammatory demyelinating polyneuropathy) that are undergoing TPE treatments. Methods: This was a prospective, non-randomized, longitudinal study of the impact of MI with patients at high risk of sense of self-burden who underwent apheresis treatments. Consented patients underwent three to six MI sessions with a trained clinician. Patients completed a self-report baseline and post-test of self-perceived burden. Results: Thirty participants consented to the study; 27 were included in the analysis. The Self-Perceived Burden Scale scores were significantly higher at baseline (m = 26.2) when compared to scores post MI sessions (m = 21.48, P <.05). The number of MI sessions (3, 4, 5, 6 sessions) did not significantly impact the outcome score (r2 = 0.001; P =.901). Conclusion: MI is a straightforward technique that is feasible and shown to be effective to be used by bedside clinicians while working with patients who receive TPE to decrease levels of self-perceived burden.
AB - Background: Autoimmune disorders and neurodegenerative disorders take a physical and emotional toll on patients that undergo therapeutic plasma exchange (TPE) treatments. Previous literature has shown that these patients may feel a greater sense of self-burden. Motivational Interviewing (MI) is a technique used in various settings that has the potential to decrease feelings of self-burden. MI for patients who receive TPE has not been tested. The purpose of this study was to examine the impact of MI in patients with a neurodegenerative diagnosis (eg, transverse myelitis, myasthenia gravis, multiple sclerosis, and chronic inflammatory demyelinating polyneuropathy) that are undergoing TPE treatments. Methods: This was a prospective, non-randomized, longitudinal study of the impact of MI with patients at high risk of sense of self-burden who underwent apheresis treatments. Consented patients underwent three to six MI sessions with a trained clinician. Patients completed a self-report baseline and post-test of self-perceived burden. Results: Thirty participants consented to the study; 27 were included in the analysis. The Self-Perceived Burden Scale scores were significantly higher at baseline (m = 26.2) when compared to scores post MI sessions (m = 21.48, P <.05). The number of MI sessions (3, 4, 5, 6 sessions) did not significantly impact the outcome score (r2 = 0.001; P =.901). Conclusion: MI is a straightforward technique that is feasible and shown to be effective to be used by bedside clinicians while working with patients who receive TPE to decrease levels of self-perceived burden.
KW - motivational interviewing
KW - nursing
KW - self-perceived burden of care
KW - therapeutic plasma exchange
UR - http://www.scopus.com/inward/record.url?scp=85052966393&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85052966393&partnerID=8YFLogxK
U2 - 10.1002/jca.21645
DO - 10.1002/jca.21645
M3 - Article
C2 - 30178480
AN - SCOPUS:85052966393
SN - 0733-2459
VL - 33
SP - 586
EP - 590
JO - Journal of Clinical Apheresis
JF - Journal of Clinical Apheresis
IS - 5
ER -